P&C
Health+Benefits
Industry
Brokerage Ops
Lifestyle
Magazine
Podcasts
Vital Signs
Health+Benefits
Gene Therapy: Rarely Needed but Massively Expensive
Health+Benefits
Loneliness Lingers
Q&A with Dr. Jeremy Nobel, Professor, Harvard Medical School, and President and ...
I think that’s the best starting point— having two traditional plan designs, and one that is a direct contract with lower copays. And then, if you see it pay out and save money, you could start offering only that plan for new employees.
Health+Benefits
Going Direct to Cut Costs
Health+Benefits
Who Benefits from Drug Price Negotiations?
Q&A with Shawn Gremminger, President and CEO, National Alliance of Healthcare Purchaser Coalitions
Health+Benefits
A Holistic Approach to Weight Loss and Illness
Q&A with Dr. Ryan Kane, Internal Medicine Fellow and Medical Instructor, Duke University Division of General Internal Medicine
Brokerage Ops
Mixing High Tech and High Touch
Q&A with Courtney Hutchison, Market President—Colorado, The MJ Companies
Health+Benefits
U.S. Healthcare System Failing New Mothers
Q&A with Munira Gunja, Senior Researcher, Commonwealth Fund International Program in Health Policy and Practice Innovations
Show More in Vital Signs